Real-world effectiveness of tafamidis in a contemporary, matched cohort of patients with variant and wild-type transthyretin amyloid cardiomyopathy
29 August 2025 (07:00 - 18:00)
Organised by: 
About the speaker
Columbia University Irving Medical Centre, New York (United States of America)
9 More presentations in this session
Mr S. Decotto (Buenos Aires, AR)
Wild-type transthyretin cardiac amyloidosis: sex differences in prevalence, phenotype, and prognosis
Assistant Professor A. Zaroui (Creteil, FR)
Access the full session
The Event
ESC Congress 2025
29 August - 1 September 2025
You may be interested in
Congress Session
